Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123863 · ClinicalTrials.gov registry record
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
A clinical trial of Sickle Cell Disease, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 248
- Enrollment target
- 1
- Study location
NCT01123863: Completed study of Sickle Cell Disease, sponsored by St. Jude Children's Research Hospital.
NCT01123863 is a study of Sickle Cell Disease that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 248 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01123863, a study of Sickle Cell Disease, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
A preliminary study was conducted involving 88 three-year-old children with sickle cell disease (SCD) who were followed at the St. Jude Children's Research Hospital Sickle Cell Center. They were offered developmental screening with the Brigance Preschool Screen-II test during their regular clinic visits from January 2006 to August 2008. Data from this work showed that 50% of 3 year old children with SCD had low developmental screening scores. In addition, the low scores were found to be associated with less parental education and with speech deficits. However they were not associated with sickle cell genotype and hemoglobin level. The primary goal of this study is to prospectively administer Brigance Preschool Screen -II to 3 year old children with SCD and 3 year old children without SCD who come from similar socioeconomic backgrounds and compare the results between the two groups.
Conditions Studied
Interventions
- OTHER Brigance Preschool Screen -II
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2010-05 |
| Est. Completion | 2015-05 |
What the finished NCT01123863 record still lists
NCT01123863 is an observational study that tracks outcomes without assigning an intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Brigance Preschool Screen -II is the first listed.
NCT01123863 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01123863 about?
NCT01123863 is a clinical study titled "The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2". A preliminary study was conducted involving 88 three-year-old children with sickle cell disease (SCD) who were followed at the St. Jude Children's Research Hospital Sickle Cell Center. They were offered developmental screening with the Brigance Preschool Screen-II test during their regular clinic vi...
What is the current status of trial NCT01123863?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2010-05. Estimated completion is 2015-05.
What conditions does trial NCT01123863 study?
This clinical trial studies the following conditions: Sickle Cell Disease.
What interventions are being tested in trial NCT01123863?
The interventions under investigation include: Brigance Preschool Screen -II (OTHER).
Who is sponsoring clinical trial NCT01123863?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01123863 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01123863's enrollment target sits among peer trials
248 29th of 213 higher than 185 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RECRUITING · Phase 2
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RECRUITING · Phase 1
-
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia